Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526428) titled 'Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment' on April 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Sonova AG

Condition: Hearing Loss

Intervention: Device: Phonak Audeo Infinio Hearing Aid

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: April 8, 2026

Target Sample Size: 21

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07526428

Publ...